On Monday, October 5, 2026, Edinburgh-based intimate-health brand GLORIAH closed an oversubscribed £600,000 seed round, beating its £500,000 target. Gabriel Investment Syndicate led the round, with Highland Venture Capital, Investing Women Angels, Apollo and Scottish Enterprise participating, according to Scottish Enterprise's media centre and FemTech World. The company sells two products for vaginal dryness, one of the most common and least discussed symptoms of menopause. Soul Gel is a naturally formulated vaginal lubricant, and Liberation Oil is designed for dryness. Both are pitched as a modern, brand-led alternative to the clinical-looking products that have long dominated the category.

Why It Matters

The round is small, and the amount isn't the news. The channel strategy is. Vaginal moisturisers and lubricants for menopause have traditionally sat on the pharmacy shelf next to thrush treatments, with pharmaceutical packaging. GLORIAH is taking the playbook that worked for pleasure-adjacent lube brands (social-first, lifestyle branding, then mass retail through Boots and QVC) into a medicalised category. That makes it a direct competitor to wellness-led menopause brands and to the sexual-wellness lube makers that have been adding "menopause-friendly" claims to their ranges. The US plan is the riskiest part. Amazon US is crowded with lubricants and has its own restricted-category rules, so a £600K budget won't buy much visibility there unless the social following converts. The "regulatory work" line is also worth watching. In both the UK and US, vaginal lubricants are generally regulated as medical devices, so a formulation claiming to treat a symptom faces more paperwork than a generic "personal lubricant." Brands that do this work early are better placed if regulators start looking harder at claims on "clean" and "natural" intimate products. It follows the Flouria (Netherlands) and Know Your Floors (UK) raises Afterglow logged last week, and fits the same pattern: women's-health funders are writing small checks for specific symptoms.

The founders are Jessica-Rose Watson, who managed product launches, subscriptions and commercial strategy at Sky, and Isla Wynne Thomas, a former nurse who worked in NHS high-dependency and menopause clinics. They started GLORIAH in 2021 after a close friend went through surgical menopause at 25 and found no modern, non-clinical products for the symptoms. Before this round the company had raised more than £110,000 in grants and prizes (FemTech World puts the figure at about £100,000) from Scottish EDGE, Young EDGE, Zero Waste Scotland, NatWest Pitch and the Amazon Sustainability Accelerator. In 2026 it went through the AccelerateHER programme and Investing Women Angels' Women to Women and Ready to Raise programmes.

The new money goes to retail expansion and the US. A Boots.com launch is planned for this month and a QVC UK slot is confirmed. GLORIAH says it has had interest from US distributors and is preparing to launch on Amazon US later this year. Scottish Enterprise says the round will also fund "progressing regulatory work" and faster marketing. The brand reports 7.5 million social media views in a single month and a community of more than 16,000 women. Those figures come from the company and have not been independently verified.

"GLORIAH exists because too many women are still expected to tolerate discomfort, embarrassment or dismissal when it comes to their intimate health," Watson said. Alex Lusty, who led the deal for Gabriel, described the result as evidence that "experienced early-stage investors from diverse backgrounds [are] viewing vaginal dryness solutions as a mainstream investment opportunity."

Sources

Update — 2026-10-06

Initial entry — story first created.